The role of inhaled long-acting beta-2 agonists in the management of asthma

被引：0
作者：
Kelly, HW
Harkins, MS
Boushey, H
机构：
[1] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Hlth Sci Ctr, Dept Pediat, Albuquerque, NM 87131 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION | 2006年 / 98卷 / 01期
关键词：
asthma; polymorphisms; lung;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The role of inhaled beta-2 agonists in the management of asthma has changed significantly over the last several years. This review outlines the most recent understanding of the pathophysiology of asthma and the studies that define the roles that both short- and long-acting beta-2 agonists play in therapy for this disease. A concentration on the clinical pharmacology and genetic implications for clinical use of this class of drugs in accordance with the national and international guidelines are described.
引用
收藏
页码：8 / 16
页数：9
相关论文
共 64 条
[1]  
*AG HEALTHC RES QU, 2001, MAN CHRON ASTHM
[2]   Interactions between corticosteroids and β-adrenergic agonists in asthma disease induction, progression, and exacerbation [J].
Anderson, GP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (03) :S188-S196
[3]   Adding formoterol to budesonide in moderate asthma -: health economic results from the FACET study [J].
Andersson, F ;
Ståhl, E ;
Barnes, PJ ;
Löfdahl, CG ;
O'Byrne, PM ;
Pauwels, RA ;
Postma, DS ;
Tattersfield, AE ;
Ullman, A .
RESPIRATORY MEDICINE, 2001, 95 (06) :505-512
[4]  
Bartow RA, 1998, DRUGS, V55, P303, DOI 10.2165/00003495-199855020-00016
[5]   A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler [J].
Bensch, G ;
Lapidus, RJ ;
Levine, BE ;
Lumry, W ;
Yegen, Ü ;
Kiselev, P ;
Della Cioppa, G .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2001, 86 (01) :19-27
[6]   Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma [J].
Bouros, D ;
Bachlitzanakis, N ;
Kottakis, J ;
Pfister, P ;
Polychronopoulos, V ;
Papadakis, E ;
Constantopoulos, S ;
Froudarakis, M ;
Sichletidis, L ;
Siafakas, N .
EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (03) :627-632
[7]   Asthma - From bronchoconstriction to airways inflammation and remodeling [J].
Bousquet, J ;
Jeffery, PK ;
Busse, WW ;
Johnson, M ;
Vignola, AM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (05) :1720-1745
[8]   Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma [J].
Busse, W ;
Nelson, H ;
Wolfe, J ;
Kalberg, C ;
Yancey, SW ;
Rickard, KA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (06) :1075-1080
[9]   The effect of salmeterol on markers of airway inflammation following segmental allergen challenge [J].
Calhoun, WJ ;
Hinton, KL ;
Kratzenberg, JJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (04) :881-886
[10]   LONG-TERM EFFECTS OF A LONG-ACTING BETA-2-ADRENOCEPTOR AGONIST, SALMETEROL, ON AIRWAY HYPERRESPONSIVENESS IN PATIENTS WITH MILD ASTHMA [J].
CHEUNG, D ;
TIMMERS, MC ;
ZWINDERMAN, AH ;
BEL, EH ;
DIJKMAN, JH ;
STERK, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (17) :1198-1203
1234567